| Covenant Waiver Extension | 30-Dec-2025 | 07:00 | RNS |
| Covenant Waiver Extension | 30-Dec-2025 | 07:00 | RNS |
| Adverse Costs Order in Class Action Investment | 24-Dec-2025 | 07:00 | RNS |
| Results of AGM | 27-Nov-2025 | 13:08 | RNS |
| Strategic Review Update | 26-Nov-2025 | 17:00 | RNS |
| Posting of Annual Report and Accounts | 19-Nov-2025 | 11:54 | RNS |
| Notice of Annual General Meeting | 04-Nov-2025 | 14:29 | RNS |
| Postponement of Annual General Meeting | 21-Oct-2025 | 11:37 | RNS |
| Exercise of Awards | 13-Oct-2025 | 11:39 | RNS |
| Update on Commercial Arbitration Loss | 06-Oct-2025 | 07:00 | RNS |
| TR-1 | 02-Oct-2025 | 08:40 | RNS |
| Notice of Annual General Meeting | 01-Oct-2025 | 16:49 | RNS |
| Judgment Delivered in Commercial Litigation Claim | 01-Oct-2025 | 11:25 | RNS |
| Annual Results for the year ended 30 June 2025 | 01-Oct-2025 | 07:00 | RNS |
| Class Action Investment and Strategic Review | 15-Sep-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 8.85p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 101.50p |
| 52 Week Low | 6.90p |
| Volume | 91 |
| Shares Issued | 114.28m |
| Market Cap | £10.11m |
| Beta | 0.15 |
| RiskGrade | 218 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 03-Oct-24 | 28-Sep-23 |
| Paid | 25-Oct-24 | 27-Oct-23 |
| Amount | 1.25p | 2.25p |
| Time | Volume / Share Price |
| 08:01 | 80 @ 9.18p |
| 08:00 | 11 @ 9.18p |
| CEO | Patrick Moloney |
| CFO | David Collins |
You are here: research